LT2948156T - Volframo (vi) druskų panaudojimas moteriško nevaisingumo gydymui žinduoliuose, nesergančiuose diabetu - Google Patents

Volframo (vi) druskų panaudojimas moteriško nevaisingumo gydymui žinduoliuose, nesergančiuose diabetu

Info

Publication number
LT2948156T
LT2948156T LTEP14701067.2T LT14701067T LT2948156T LT 2948156 T LT2948156 T LT 2948156T LT 14701067 T LT14701067 T LT 14701067T LT 2948156 T LT2948156 T LT 2948156T
Authority
LT
Lithuania
Prior art keywords
tungsten
salts
treatment
female infertility
diabetic mammals
Prior art date
Application number
LTEP14701067.2T
Other languages
English (en)
Inventor
Ignacio Canals Almazan
Agnes Arbat Bugié
Original Assignee
Oxolife, S.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49999950&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT2948156(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Oxolife, S.L. filed Critical Oxolife, S.L.
Publication of LT2948156T publication Critical patent/LT2948156T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/14Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Pregnancy & Childbirth (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Physiology (AREA)
LTEP14701067.2T 2013-01-22 2014-01-21 Volframo (vi) druskų panaudojimas moteriško nevaisingumo gydymui žinduoliuose, nesergančiuose diabetu LT2948156T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201330071A ES2478790B1 (es) 2013-01-22 2013-01-22 Uso de sales de tungsteno (VI) para el tratamiento de la infertilidad femenina en mamíferos no diabéticos
PCT/EP2014/051141 WO2014114644A1 (en) 2013-01-22 2014-01-21 Use of tungsten (vi) salts for the treatment of female infertility in non-diabetic mammals

Publications (1)

Publication Number Publication Date
LT2948156T true LT2948156T (lt) 2016-12-27

Family

ID=49999950

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP14701067.2T LT2948156T (lt) 2013-01-22 2014-01-21 Volframo (vi) druskų panaudojimas moteriško nevaisingumo gydymui žinduoliuose, nesergančiuose diabetu

Country Status (27)

Country Link
US (1) US9675638B2 (lt)
EP (1) EP2948156B1 (lt)
JP (1) JP6045721B2 (lt)
KR (1) KR102182563B1 (lt)
CN (1) CN105188721B (lt)
AU (1) AU2014209987B2 (lt)
BR (1) BR112015017483A2 (lt)
CA (1) CA2898953C (lt)
CL (1) CL2015002047A1 (lt)
CY (1) CY1118287T1 (lt)
DK (1) DK2948156T3 (lt)
ES (2) ES2478790B1 (lt)
HK (1) HK1217442A1 (lt)
HR (1) HRP20161611T1 (lt)
HU (1) HUE031910T2 (lt)
IL (1) IL240062B (lt)
LT (1) LT2948156T (lt)
MX (1) MX356851B (lt)
NZ (1) NZ710583A (lt)
PL (1) PL2948156T3 (lt)
PT (1) PT2948156T (lt)
RS (1) RS55418B1 (lt)
RU (1) RU2635507C2 (lt)
SG (1) SG11201505701WA (lt)
SI (1) SI2948156T1 (lt)
SM (1) SMT201700018B (lt)
WO (1) WO2014114644A1 (lt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2551828B1 (es) * 2014-05-21 2016-09-12 Oxolife S.L. Composiciones alimentarias que comprenden sales de tungsteno (VI)
ES2639588B1 (es) * 2014-05-21 2018-09-06 Oxolife, S.L. Uso de una sal de tungsteno (VI) para favorecer la fertilidad y la reproducción normal en un mamífero hembra no diabético
CA2955914C (en) * 2014-07-21 2022-09-06 Ignacio Canals Almazan Tungsten (vi) salts for use thereof in the treatment of infertility, for favoring normal reproduction and fertility in a non-diabetic female mammal, as well as for improving the efficacy of assisted reproductive techniques
EP4368577A1 (en) * 2022-11-08 2024-05-15 Oxolife, S.L. Process for the preparation of tungsten (vi) salt hydrates

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4328134A (en) * 1980-05-06 1982-05-04 Schally Andrew Victor Anorexigenic peptides
ES2108642B1 (es) * 1995-07-26 1998-08-16 Quimica Farm Bayer Sa Composiciones de tungsteno (vi) para el tratamiento oral de la diabetes mellitus.
RU2141361C1 (ru) * 1998-03-12 1999-11-20 Пермская государственная медицинская академия Способ лечения ановуляторного бесплодия при ожирении
ES2187276B1 (es) * 2001-05-16 2004-08-01 Quimica Farmaceutica Bayer,S.A. Composiciones orales para el tratamiento de humanos obesos y no diabeticos.
WO2004030687A1 (en) * 2002-10-02 2004-04-15 Yeda Research And Development Co. Ltd. Long-acting gonadotropin-releasing hormone analogs and methods of use thereof
RU2270684C1 (ru) * 2005-01-20 2006-02-27 Анатолий Григорьевич Гриценко Лекарственный препарат "витасорб"
EP1972342A4 (en) * 2005-07-29 2011-01-12 Univ Barcelona PHARMACEUTICAL TREATED SALT (VI) COMPOSITIONS FOR THE TREATMENT OF NEURODEEGENERATIVE DISORDERS, IN PARTICULAR ALZHEIMER DISEASE AND SCHIZOPHRENIA
US20060100154A1 (en) * 2005-10-13 2006-05-11 Yeda Research And Development Co Long-acting gonadotropin-releasing hormone analogs and methods of use thereof

Also Published As

Publication number Publication date
SI2948156T1 (sl) 2017-02-28
ES2611776T3 (es) 2017-05-10
ES2478790B1 (es) 2015-05-06
US9675638B2 (en) 2017-06-13
JP6045721B2 (ja) 2016-12-14
CL2015002047A1 (es) 2016-01-04
JP2016505057A (ja) 2016-02-18
KR102182563B1 (ko) 2020-11-25
EP2948156A1 (en) 2015-12-02
KR20150130992A (ko) 2015-11-24
CA2898953C (en) 2018-01-02
BR112015017483A2 (pt) 2017-07-11
IL240062B (en) 2018-11-29
EP2948156B1 (en) 2016-10-26
US20150359820A1 (en) 2015-12-17
ES2478790A1 (es) 2014-07-22
SMT201700018B (it) 2017-03-08
HRP20161611T1 (hr) 2017-01-27
MX2015009364A (es) 2016-03-08
PL2948156T3 (pl) 2017-07-31
WO2014114644A1 (en) 2014-07-31
DK2948156T3 (da) 2017-01-02
RS55418B1 (sr) 2017-04-28
AU2014209987B2 (en) 2016-09-01
HUE031910T2 (en) 2017-08-28
SG11201505701WA (en) 2015-08-28
NZ710583A (en) 2016-06-24
PT2948156T (pt) 2016-11-30
RU2015135578A (ru) 2017-03-02
CA2898953A1 (en) 2014-07-31
HK1217442A1 (zh) 2017-01-13
CN105188721A (zh) 2015-12-23
RU2635507C2 (ru) 2017-11-13
CN105188721B (zh) 2017-10-31
MX356851B (es) 2018-06-18
AU2014209987A1 (en) 2016-01-21
CY1118287T1 (el) 2017-06-28
IL240062A0 (en) 2015-09-24

Similar Documents

Publication Publication Date Title
IL283943A (en) Use of pyrazolopyrimidine derivatives for the treatment of p13k associated disorders
HK1244197A1 (zh) 用於青光眼治療的系統
IL243976B (en) kdm1a inhibitors for disease treatment
PL3811943T3 (pl) Związek do stosowania w leczeniu zaburzeń oczu
EP3015480A4 (en) Surface treatment agent
HK1219653A1 (zh) 治療線粒體疾病的方法
EP2990419A4 (en) Preventive or therapeutic agent for inflammatory disease
EP2968204A4 (en) TREATMENT WITH A PHOSPHODIESTERASE HEMMER
HK1217442A1 (zh) 鹽用於治療非糖尿病哺乳動物的雌性不育症的用途
HK1221166A1 (zh) 炎症性病症的治療
EP3079685A4 (en) Sulfamate derivative compounds for use in treating or alleviating pain
EP3079687A4 (en) Sulfamate derivative compounds for use in treating or alleviating pain
PL3137102T3 (pl) Apc do stosowania w leczeniu nieprawidłowego bliznowacenia skóry
EP2958570A4 (en) THERAPEUTIC COMPOSITION FOR THE TREATMENT OF PERIANAL DISORDERS
GB2520040B (en) Tablet tooling surface treatment
GB201314623D0 (en) Novel mucinase for use in therapy or prophylaxis